EBOS Group Limited (ASX:EBO)
Australia · Delayed Price · Currency is AUD 22.15
+0.33 (1.51%)
At close: Feb 5, 2026
EBOS Group Market Cap
EBOS Group has a market cap or net worth of 4.51 billion as of February 5, 2026. Its market cap has decreased by -30.02% in one year.
Market Cap
4.51B
Enterprise Value
5.82B
Revenue
12.27B
Ranking
n/a
PE Ratio
20.94
Stock Price
22.15
Market Cap Chart
Since August 30, 1999, EBOS Group's market cap has increased from 37.66M to 4.51B, an increase of 11,863.67%. That is a compound annual growth rate of 19.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 4.51B | -7.75% |
| Dec 31, 2025 | 4.88B | -25.18% |
| Dec 31, 2024 | 6.53B | 3.20% |
| Dec 29, 2023 | 6.33B | -18.95% |
| Dec 30, 2022 | 7.81B | 9.56% |
| Dec 31, 2021 | 7.12B | 62.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 87.60B |
| Pro Medicus | 17.38B |
| Cochlear | 17.00B |
| Sonic Healthcare | 11.26B |
| Ramsay Health Care | 8.29B |
| Ansell | 4.67B |
| Telix Pharmaceuticals | 3.43B |
| Mesoblast | 3.21B |